Intuitive Surgical, Inc. (NASDAQ:ISRG – Get Free Report) CFO Jamie Samath sold 108 shares of Intuitive Surgical stock in a transaction on Tuesday, November 26th. The shares were sold at an average price of $542.06, for a total transaction of $58,542.48. Following the completion of the sale, the chief financial officer now directly owns 8,757 shares of the company’s stock, valued at approximately $4,746,819.42. This trade represents a 1.22 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink.
Jamie Samath also recently made the following trade(s):
- On Friday, November 8th, Jamie Samath sold 22,903 shares of Intuitive Surgical stock. The shares were sold at an average price of $525.00, for a total value of $12,024,075.00.
- On Monday, November 11th, Jamie Samath sold 269 shares of Intuitive Surgical stock. The shares were sold at an average price of $539.89, for a total value of $145,230.41.
Intuitive Surgical Stock Up 1.0 %
Shares of NASDAQ ISRG traded up $5.55 during mid-day trading on Tuesday, reaching $542.10. 1,152,557 shares of the company were exchanged, compared to its average volume of 1,457,655. The company’s 50 day moving average price is $506.81 and its 200 day moving average price is $466.29. Intuitive Surgical, Inc. has a 52 week low of $304.50 and a 52 week high of $552.00. The stock has a market capitalization of $193.09 billion, a PE ratio of 87.15, a PEG ratio of 5.39 and a beta of 1.39.
Analyst Upgrades and Downgrades
A number of brokerages have commented on ISRG. Erste Group Bank raised Intuitive Surgical from a “hold” rating to a “buy” rating in a report on Tuesday, November 19th. Redburn Atlantic raised shares of Intuitive Surgical from a “neutral” rating to a “buy” rating and lifted their price target for the stock from $380.00 to $510.00 in a report on Friday, August 2nd. Evercore ISI reissued a “cautious” rating on shares of Intuitive Surgical in a research report on Friday, October 18th. Citigroup lifted their target price on shares of Intuitive Surgical from $512.00 to $560.00 and gave the stock a “buy” rating in a research note on Thursday, August 22nd. Finally, Royal Bank of Canada upped their price target on shares of Intuitive Surgical from $525.00 to $555.00 and gave the company an “outperform” rating in a research note on Friday, October 18th. One equities research analyst has rated the stock with a sell rating, five have given a hold rating and fourteen have assigned a buy rating to the company’s stock. Based on data from MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus target price of $526.06.
Read Our Latest Stock Analysis on ISRG
Institutional Investors Weigh In On Intuitive Surgical
Institutional investors have recently bought and sold shares of the stock. Ridgewood Investments LLC purchased a new stake in shares of Intuitive Surgical during the second quarter valued at approximately $26,000. Godsey & Gibb Inc. raised its holdings in Intuitive Surgical by 140.0% during the 3rd quarter. Godsey & Gibb Inc. now owns 60 shares of the medical equipment provider’s stock valued at $29,000 after buying an additional 35 shares during the last quarter. Creekmur Asset Management LLC boosted its position in Intuitive Surgical by 200.0% during the 1st quarter. Creekmur Asset Management LLC now owns 63 shares of the medical equipment provider’s stock valued at $25,000 after buying an additional 42 shares during the period. LGT Financial Advisors LLC boosted its position in Intuitive Surgical by 415.4% during the 2nd quarter. LGT Financial Advisors LLC now owns 67 shares of the medical equipment provider’s stock valued at $30,000 after buying an additional 54 shares during the period. Finally, MidAtlantic Capital Management Inc. purchased a new position in shares of Intuitive Surgical in the third quarter valued at about $33,000. 83.64% of the stock is currently owned by hedge funds and other institutional investors.
About Intuitive Surgical
Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.
Further Reading
- Five stocks we like better than Intuitive Surgical
- Investing In Preferred Stock vs. Common Stock
- Cerence Up 155% in 2 Days: SoundHound AI’s Fierce Competitor
- What Are Dividends? Buy the Best Dividend Stocks
- Why Warren Buffett Is Selling: A Look at His Latest Market Moves
- The Top 3 Healthcare Dividend Stocks to Buy and Hold
- Why Amazon Shares May Never Trade Below $200 Again
Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.